Pro-Dex Inc
$ 65.21
-2.67%
05 Jun - close price
- Market Cap 213,915,000 USD
- Current Price $ 65.21
- High / Low $ 67.78 / 65.21
- Stock P/E 18.46
- Book Value 14.14
- EPS 3.63
- Next Earning Report 2026-08-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.30 %
- 52 Week High 68.99
- 52 Week Low 23.47
About
Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company is headquartered in Irvine, California.
Analyst Target Price
$70.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-01-29 | 2025-10-30 | 2025-09-04 | 2025-05-01 | 2025-01-30 | 2024-10-31 | 2024-09-05 | 2024-05-02 | 2024-02-08 | 2023-10-13 | 2023-09-29 |
| Reported EPS | 1.2 | 0.6619 | 1.4 | 0.36 | 0.85 | 0.61 | 0.75 | 0.46 | 0.19 | 0.14 | -0.17 | 0.42 |
| Estimated EPS | 0.62 | 0.59 | 0.5 | 0.47 | 0.47 | 0.38 | 0.29 | 0.35 | 0.35 | 0.35 | 0.32 | 0.33 |
| Surprise | 0.58 | 0.0719 | 0.9 | -0.11 | 0.38 | 0.23 | 0.46 | 0.11 | -0.16 | -0.21 | -0.49 | 0.09 |
| Surprise Percentage | 93.5484% | 12.1864% | 180% | -23.4043% | 80.8511% | 60.5263% | 158.6207% | 31.4286% | -45.7143% | -60% | -153.125% | 27.2727% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-25 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.66 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PDEX
2026-05-27 02:09:10
Pro Dex CEO and Director Richard Lee Van Kirk Jr. sold 10,000 shares of company common stock for approximately $626,247 over two days in May 2026. The sales were conducted under a Rule 10b5-1 trading plan and occurred while the stock was trading near its 52-week high, after a 77% surge. InvestingPro analysis suggests the stock is currently overvalued.
2026-05-27 00:09:00
Richard Lee Van Kirk Jr., CEO and Director at PRO DEX INC (NASDAQ:PDEX), sold approximately $626,247 worth of company common stock over May 21 and May 22, 2026. These transactions involved 10,000 shares sold at prices between $62.09 and $63.92, following a 77% stock surge and trading near its 52-week high. The sales were conducted under a Rule 10b5-1 trading plan, and Mr. Van Kirk Jr. now directly holds 89,707 shares, with InvestingPro suggesting the stock is overvalued.
2026-05-25 15:09:27
This article reports on a Form 144 SEC filing by PRO DEX INC (PDEX). The filing indicates a proposed sale of 10,000 common shares by an individual, acquired through stock option exercises in 2021 and 2022, with an aggregate market value of $628,417.00. The sale is planned for May 21, 2026, on NASDAQ through The Charles Schwab Corporation.
2026-05-03 16:39:24
Pro-Dex, Inc. reported a 15% increase in Q3 2026 revenue to $19.9 million and a 16% increase for the nine months ended March 31, 2026, reaching $57.1 million. Diluted EPS rose to $1.20 for the quarter and $3.27 for the nine-month period, significantly boosted by realized gains from contingent value rights related to Monogram Technologies. While gross margin decreased due to an unfavorable product mix, the company saw growth driven by its largest customer's next-generation orthopedic handpiece and the acquisition of Advanced Precision Machining.
2026-05-01 16:09:01
Pro-Dex (PDEX) reported strong financial results for Q3 2026, with revenue reaching $19.9 million and net income at $3.9 million, primarily driven by increased sales of medical devices, especially orthopedic products. The company also completed the acquisition of Advanced Precision Machining, LLC for $8.65 million, expanding its machining capacity and diversifying into the aerospace and defense sectors. Overall, Pro-Dex demonstrated significant nine-month growth, strategic investment gains from its Monogram investment, and enhanced liquidity despite increased debt to fund the acquisition.
2026-05-01 03:08:57
Pro-Dex (PDEX) announced record Q3 fiscal 2026 net sales of $19.9 million, a 15% increase year-over-year, and diluted EPS of $1.20, primarily driven by shipments of its next-generation orthopedic handpiece. The company's net income for the quarter was $3.9 million, benefiting from a $2.3 million realized gain from Monogram Technologies contingency rights. Pro-Dex also completed the acquisition of Advanced Precision Machining, which contributed to increased operating expenses but is expected to add new revenue streams and expand machining capacity.
